Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-22T18:29:56.743Z Has data issue: false hasContentIssue false
  • English
  • Français

Association Study of the HTR2C, Leptin and Adiponectin Genes and Serum Marker Analyses in Clozapine Treated Long-Term Patients with Schizophrenia

Published online by Cambridge University Press:  15 April 2020

J.-P. Klemettilä ,
O. Kampman ,
N. Seppälä ,
M. Viikki ,
M. Hämäläinen ,
E. Moilanen ,
N. Mononen ,
T. Lehtimäki  and
E. Leinonen
J.-P. Klemettilä*
Affiliation:
Department of Psychiatry, Pitkäniemi Hospital, Tampere University Hospital, 33380Pitkäniemi, Finland
O. Kampman
Affiliation:
School of Medicine, University of Tampere, 33014Tampere, Finland Department of Psychiatry, Seinäjoki Hospital District, 60220Seinäjoki, Finland
N. Seppälä
Affiliation:
Department of Psychiatry, Satakunta Hospital District, 28500Pori, Finland
M. Viikki
Affiliation:
School of Medicine, University of Tampere, 33014Tampere, Finland Tampere Mental Health Centre, Hallituskatu 8B, 33200Tampere, Finland
M. Hämäläinen
Affiliation:
The Immunopharmacology Research Group, School of Medicine, University of Tampere and Tampere University Hospital, 33014Tampere, Finland
E. Moilanen
Affiliation:
The Immunopharmacology Research Group, School of Medicine, University of Tampere and Tampere University Hospital, 33014Tampere, Finland
N. Mononen
Affiliation:
Fimlab Laboratories, Department of Clinical Chemistry, School of Medicine, University of Tampere, 33014Tampere, Finland
T. Lehtimäki
Affiliation:
Fimlab Laboratories, Department of Clinical Chemistry, School of Medicine, University of Tampere, 33014Tampere, Finland
E. Leinonen
Affiliation:
Department of Psychiatry, Pitkäniemi Hospital, Tampere University Hospital, 33380Pitkäniemi, Finland School of Medicine, University of Tampere, 33014Tampere, Finland
*
*Corresponding author. Department of Psychiatry, Pitkäniemi Hospital, Tampere University Hospital, 33380 Pitkäniemi, Finland. Tel.: +358 50 5928308. E-mail address:[email protected] (J.-P. Klemettilä).
Get access

Abstract

Clozapine treatment is associated with weight gain and cardio-metabolic consequences among patients with schizophrenia. Polymorphisms of leptin, serotonin receptor HTR2 C and adiponectin genes have been associated with antipsychotic-induced weight gain and metabolic comorbidity. However, the results of the studies so far are inconclusive. The aim of the present study was first to test for a possible role of serum leptin and adiponectin levels as a marker of weight gain in association with inflammatory cytokines/adipokines (IL-6, IL-1Ra, hs-CRP and adipsin), and second to study associations between SNPs LEP rs7799039 (-2548 A/G), ADIPOQ rs1501299 and HTR2 C rs1414334 and weight gain and levels of leptin and adiponectin, in 190 patients with schizophrenia on clozapine treatment, with retrospectively assessed weight change and cross-sectionally measured cytokine levels. A strong association was found between serum levels of leptin and weight gain and cytokines/adipokines related to metabolic comorbidity, especially among female patients (in women leptin vs. weight gain, IL-6 and IL-1Ra, P < 0.001; in men leptin vs. weight gain, P = 0.026, leptin vs. IL-1Ra, P < 0.001). In male patients low adiponectin level was a more specific marker of clozapine-induced weight gain (P = 0.037). The results of the present study do not support a major role of SNPs LEP rs7799039, ADIPOQ rs1501299 and HTR2 C rs1414334 in the regulation of weight gain or association of serum levels of leptin and adiponectin and corresponding studied SNPs in patients with schizophrenia on clozapine treatment.

Keywords

AdipsinAdipokineCytokiners1414334rs7799039rs1501299Weight gain
Type
Original article
Information
European Psychiatry , Volume 30 , Issue 2 , February 2015 , pp. 296 - 302
Copyright
Copyright © Elsevier Masson SAS 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andreasson, A.N., Undén, A.L., Elofsson, S., Brismar, K.Leptin and adiponectin: distribution and associations with cardiovascular risk factors in men and women of the general population. Am J Hum Biol 2012;24 :595–601.CrossRefGoogle ScholarPubMed
Arranz, M.J., Rivera, M., Munro, J.C.Pharmacogenetics of response to antipsychotics in patients with schizophrenia. CNS Drugs 2011;25 :933–969.CrossRefGoogle ScholarPubMed
Asarian, L., Geary, N.Sex differences in the physiology of eating. Am J Physiol Regul Integr Comp Physiol 2013;305 :R1215–R1267.CrossRefGoogle ScholarPubMed
Bai, Y.M., Chen, J.Y., Yang, W.S., Chi, Y.C., Liou, Y.J., Lin, C.C., et al.Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia. J Clin Psychiatry 2007;68 :1834–1839.CrossRefGoogle Scholar
Beumer, W., Drexhage, R.C., De Wit, H., Versnel, M.A., Drexhage, H.A., Cohen, D.Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology 2012;37 :1901–1911.CrossRefGoogle ScholarPubMed
Brandl, E.J., Frydrychowicz, C., Tiwari, A.K., Lett, T.A., Kitzrow, W., Büttner, S., et al.Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain. Prog Neuropsychopharmacol Biol Psychiatry 2012;38 :134–141.CrossRefGoogle ScholarPubMed
Brandl, E.J., Kennedy, J.L., Müller, D.J.Pharmacogenetics of antipsychotics. Can J Psychiatry 2014;59 :76–88.CrossRefGoogle ScholarPubMed
Brown, L.M., Clegg, D.J.Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol 2010;122 :65–73.CrossRefGoogle ScholarPubMed
Canfrán-Duque, A., Casado, M.E., Pastor, O., Sánchez-Wandelmer, J., de la Peña, G., Lerma, M., et al.Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro. J Lipid Res 2013;54 :310–324.CrossRefGoogle ScholarPubMed
De Hert, M., Schreurs, V., Vancampfort, D., Van Winkel, R.Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 2009;8 :15–22.CrossRefGoogle ScholarPubMed
Derosa, G., Fogari, E., D’Angelo, A., Bianchi, L., Bonaventura, A., Romano, D., et al.Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation 2013;36 :914–920.CrossRefGoogle ScholarPubMed
Dupont, W.D., Plummer, W.D. Jr.Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998;19 :589–601.CrossRefGoogle ScholarPubMed
Elias, A.N., Hofflich, H.Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications. Am J Med 2008;121 :98–104.CrossRefGoogle ScholarPubMed
Fantuzzi, G.Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115 :911–919.CrossRefGoogle ScholarPubMed
Fernø, J., Vik-Mo, A.O., Jassim, G., Håvik, B., Berge, K., Skrede, S., et al.Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology 2009;203 :73–84.CrossRefGoogle ScholarPubMed
Fitzgerald, P.B., Scaffidi, A., Morris, M.J., de Castella, A.R., Kulkarni, J.The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain. Hum Psychopharmacol 2003;18 :551–557.CrossRefGoogle ScholarPubMed
Gregoor, J.G., Mulder, H., Cohen, D., van Megen, H.J., Egberts, T.C., Heerdink, E.R., et al.Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication. J Clin Psychopharmacol 2010;30 :702–705.CrossRefGoogle ScholarPubMed
Gregoor, J.G., van der Weide, J., Loovers, H.M., van Megen, H.J., Egberts, T.C., Heerdink, E.R.Polymorphisms of the LEP, LEPR and HTR2 C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting. Pharmacogenomics 2011;12 :919–923.CrossRefGoogle Scholar
Gregoor, J.G., van der Weide, J., Mulder, H., Cohen, D., van Megen, H.J., Egberts, A.C., et al.Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication. J Clin Psychopharmacol 2009;29 :21–25.CrossRefGoogle ScholarPubMed
Gui, M.H., Li, X., Jiang, S.F., Gao, J., Lu, D.R., Gao, X.Association of the adiponectin gene rs1501299 G > T variant, serum adiponectin levels, and the risk of coronary artery disease in a Chinese population. Diabetes Res Clin Pract 2012;97 :499–504.CrossRefGoogle Scholar
Gustafson, B.Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010;17 :332–341.CrossRefGoogle ScholarPubMed
Hanssens, L., van Winkel, R., Wampers, M., VanEyck, D., Scheen, A., Reginster, J.Y., et al.A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder. Schizophr Res 2008;106 :308–314.CrossRefGoogle ScholarPubMed
Harwood, H.J. Jr.The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 2012;63 :57–75.CrossRefGoogle ScholarPubMed
Hayes, E., Gavrulidis, E., Kulkarni, J.The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia. Schizophr Res Treatment 2012;2012 :540273.CrossRefGoogle ScholarPubMed
Heid, I.M., Henneman, P., Hicks, A., Coassin, S., Winkler, T., Aulchenko, Y.S., et al.Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010;208 :412–420.CrossRefGoogle ScholarPubMed
Houston, J.P., Kohler, J., Bishop, J.R., Ellingrod, V.L., Ostbye, K.M., Zhao, F., et al.Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia. J Clin Psychiatry 2012;73 :1077–1086.CrossRefGoogle ScholarPubMed
Huang, X.F., Deng, G., Zavitsanou, K.Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats. Neuropeptides 2006;40 :213–219.CrossRefGoogle ScholarPubMed
Jassim, G., Fernø, J., Theisen, F.M., Haberhausen, M., Christoforou, A., Håvik, B., et al.Association study of energy homeostasis genes and antipsychotic-induced weight gain in patients with schizophrenia. Pharmacopsychiatry 2011;44 :15–20.Google ScholarPubMed
Jin, H., Meyer, J.M., Mudaliar, S., Jeste, D.V.Impact of atypical antipsychotic therapy on leptin, ghrelin and adiponectin. Schizophr Res 2008;100 :70–85.CrossRefGoogle ScholarPubMed
Kirk, S.L., Cahir, M., Reynolds, G.P.Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus. J Psychopharmacol 2006;20 :577–579.CrossRefGoogle Scholar
Klemettilä, J.-P., Kampman, O., Seppälä, N., Viikki, M., Hämäläinen, M., Moilanen, E., et al.Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine. Psychiatry Res 2014;218 :277–283.CrossRefGoogle ScholarPubMed
Kuo, P.H., Kao, C.F., Chen, P.Y., Chen, C.H., Tsai, Y.S., Lu, M.L., et al.Polymorphisms of INSIG2, MC4R, and LEP are associated with obesity- and metabolic-related traits in schizophrenic patients. J Clin Psychopharmacol 2011;31 :705–711.CrossRefGoogle ScholarPubMed
Kuo, S.-M., Halpern, M.M.Lack of association between body mass index and plasma adiponectin levels in healthy adults. Int J Obes 2011;35 :1487–1494.CrossRefGoogle ScholarPubMed
Lee, Y.H., Kim, J.H., Song, G.G.Pathway analysis of a genome-wide association study in schizophrenia. Gene 2013;525 :107–115.CrossRefGoogle Scholar
Leu, H.B., Chung, C.M., Lin, S.J., Jong, Y.S., Pan, W.H., Chen, J.W.Adiponectin gene polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension. PLoS ONE 2011;6 :e19999.CrossRefGoogle ScholarPubMed
Li, L., Wu, R., Zhao, J.Adiponectin gene +45 T/G and +276G/T polymorphism and antipsychotic-induced weight gain. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009;34 :693–696.Google Scholar
Matsuda, Y., Tanioka, T., Yoshioka, T., Nagano, T., Hiroi, T., Yoshikawa, K., et al.Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non-diabetic Japanese patients with schizophrenia. Psychiatry Clin Neurosci 2005;59 :266–273.CrossRefGoogle ScholarPubMed
Miller, D.D., Ellingrod, V.L., Holman, T.L., Buckley, P.F., Arndt, S.Clozapine-induced weight gain associated with the 5HT2 C receptor-759 C/T polymorphism. Am J Med Genet B Neuropsychiatr Genet 2005;133B :97–100.CrossRefGoogle Scholar
Mou, X.D., Zhang, Z.J., Zhang, X.R., Shi, J.B., Sun, J.-2584G/A functional polymorphism in the promoter region of leptin gene and antipsychotic agent-induced weight gain in schizophrenic patients: a study of nuclear family-based association (Abstract, Article in Chinese). Zhong Nan Da Xue Xue Bao Yi Xue Ban 2008;33 :316–320.Google Scholar
Mousavinasab, F., Tähtinen, T., Jokelainen, J., Koskela, P., Vanhala, M., Oikarinen, J., et al.Common polymorphisms (single-nucleotide polymorphisms SNP + 45 and SNP + 276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. Mol Genet Metab 2006;87 :147–151.CrossRefGoogle ScholarPubMed
Mulder, H., Cohen, D., Scheffer, H., Gispen-de Wied, C., Arends, J., Wilmink, F.W., et al.HTR2 C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study. J Clin Psychopharmacol 2009;29 :16–20.CrossRefGoogle Scholar
Mulder, H., Franke, B., van der-Beek van der, A.A., Arends, J., Wilmink, F.W., Scheffer, H., et al.The association between HTR2 C gene polymorphisms and the metabolic syndrome in patients with schizophrenia. J Clin Psychopharmacol 2007;27 :338–343.CrossRefGoogle Scholar
Mulder, H., Franke, B., van der-Beek van der, A.A., Arends, J., Wilmink, F.W., Egberts, A.C., et al.The association between HTR2 C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study. Pharmacogenomics J 2007;7 :318–324.CrossRefGoogle Scholar
Napolitano, A., Lowell, B.B., Damm, D., Leibel, B.L., Ravussin, E., Jimerson, D.C., et al.Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass. Int J Obes Relat Disord 1994;18 :213–218.Google ScholarPubMed
Newcomer, J.W.Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005;19 (Suppl. 1):1–93.CrossRefGoogle ScholarPubMed
Oh, J.E., Cho, Y.M., Kwak, S.N., Kim, J.H., Lee, K.W., Jung, H., et al.Inhibition of mouse brown adipocyte differentiation by second- generation antipsychotics. Exp Mol Med 2012;44 :545–553.CrossRefGoogle ScholarPubMed
Opgen-Rhein, C., Brandl, E.J., Müller, D.J., Neuhaus, A.H., Tiwari, A.K., Sander, T., et al.Association of HTR2 C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample. Pharmacogenomics 2010;11 :773–780.CrossRefGoogle Scholar
Osby, U., Correia, N., Brandt, L., Ekbom, A., Sparen, P.Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000;45 :21–28.CrossRefGoogle ScholarPubMed
Panariello, F., Polsinelli, G., Borlido, C., Monda, M., De Luca, V.The Role of leptin in antipsychotic-induced weight gain: Genetic and non-genetic factors. J Obes 2012;2012 :572848139.CrossRefGoogle ScholarPubMed
Plaisance, E.P., Grandjean, P.W., Judd, R.L., Jones, K.W., Taylor, J.K.The influence of sex, body composition, and nonesterified fatty acids on serum adipokine concentrations. Metabolism 2009;58 :1557–1563.CrossRefGoogle ScholarPubMed
Polymeropoulos, M.H., Licamele, L., Volpi, S., Mack, K., Mitkus, S.N., Carstea, E.D., et al.Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia. Schizophr Res 2009;108 :134–142.CrossRefGoogle Scholar
Ramya, K., Ayyappa, K.A., Ghosh, S., Mohan, V., Radha, V.Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene 2013;532 :253–262.CrossRefGoogle ScholarPubMed
Raucci, R., Rusolo, F., Sharma, A., Colonna, G., Castello, G., Costantini, S.Functional and structural features of adipokine family. Cytokine 2013;61 :1–14.CrossRefGoogle ScholarPubMed
Reynolds, G.P., Hill, M.J., Kirk, S.L.The 5-HT2 C receptor and antipsychotic induced weight gain–mechanisms and genetics. J Psychopharmacol 2006;20 :15–18.CrossRefGoogle Scholar
Richards, A.A., Hickman, I.J., Wang, A.Y., Jones, A.L., Newell, F., Mowry, B.J., et al.Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia. J Clin Psychopharmacol 2006;26 :232–237.CrossRefGoogle ScholarPubMed
Risselada, A.J., Vehof, J., Bruggeman, R., Wilffert, B., Cohen, D., Al Hadithy, A.F., et al.Association between HTR2 C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study. Pharmacogenomics J 2012;12 :62–67.CrossRefGoogle Scholar
Rossi, I.A., Bochud, M., Bovet, P., Paccaud, F., Waeber, G., Vollenweider, P., et al.Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations. Eur J Epidemiol 2012;27 :379–384.CrossRefGoogle ScholarPubMed
Saltevo, J., Vanhala, M., Kautiainen, H., Kumpusalo, E., Laakso, M.Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome. Mediators Inflamm 2007;2007 :93573.CrossRefGoogle ScholarPubMed
Santaniemi, M., Kesäniemi, Y.A., Ukkola, O.Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 2006;155 :745–750.CrossRefGoogle ScholarPubMed
Sentissi, O., Epelbaum, J., Oli’e, J.P., Poirier, M.F.Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review. Schizophr Bull 2008;34 :1189–1199.CrossRefGoogle ScholarPubMed
Shi, H., Seeley, R.J., Clegg, D.J.Sexual differences in the control of energy homeostasis. Front Neuroendocrinol 2009;30 :396–404.CrossRefGoogle ScholarPubMed
Sicard, M.N., Zai, C.C., Tiwari, A.K., Souza, R.P., Meltzer, H.Y., Lieberman, J.A., et al.Polymorphisms of the HTR2 C gene and antipsychotic-induced weight gain: an update and meta-analysis. Pharmacogenomics 2010;11 :1561–1571.CrossRefGoogle Scholar
Siitonen, N., Pulkkinen, L., Linström, J., Kolehmainen, M., Eriksson, J.G., Venojärvi, M., et al.Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med Genet 2011;12 :5.CrossRefGoogle ScholarPubMed
Sugai, T., Suzuki, Y., Fukui, N., Ono, S., Watanabe, J., Tsuneyama, N., et al.Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia. J Clin Psychopharmacol 2012;32 :390–393.CrossRefGoogle ScholarPubMed
Suvisaari, J., Loo, B.M., Saarni, S.E., Haukka, J., Perälä, J., Saarni, S.I., et al.Inflammation in psychotic disorders: a population-based study. Psychiatry Res 2011;189 :305–311.CrossRefGoogle ScholarPubMed
Schwarz, E., Steiner, J., Guest, P.C., Bogerts, B., Bahn, S.Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain. World J Biol Psychiatry 2013 [Epub ahead of print].Google ScholarPubMed
Tiwari, A.K., Brandl, E.J., Weber, C., Likhodi, O., Zai, C.C., Hahn, M.K., et al.Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients. J Clin Psychopharmacol 2013;33 :11–17.CrossRefGoogle ScholarPubMed
Togo, T., Kojima, K., Shoji, M., Kase, A., Uchikado, H., Katsuse, O., et al.Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study. Int Clin Psychopharmacol 2004;19 :37–40.CrossRefGoogle ScholarPubMed
Tong, G., Wang, N., Leng, J., Tong, X., Shen, Y., Yang, J., et al.Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes. Cardiovasc Diabetol 2013;12 :67.CrossRefGoogle ScholarPubMed
Ukkola, O., Chagnon, M., Tremblay, A., Bouchard, C.Genetic variation at the adipsin locus and response to long-term overfeeding. Eur J Clin Nutr 2003;57 :1073–1078.CrossRefGoogle ScholarPubMed
Venkatasubramanian, G., Chittiprol, S., Neelakantachar, N., Shetty, T.K., Gangadhar, B.N.A longitudinal study on the impact of antipsychotic treatment on serum leptin in schizophrenia. Clin Neuropharmacol 2010;33 :288–292.CrossRefGoogle Scholar
Wampers, M., Hanssens, L., Van Winkel, R., Heald, A., Collette, J., Peuskens, J., et al.Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study. Eur Neuropsychopharmacol 2012;22 :17–26.CrossRefGoogle ScholarPubMed
Wang, H.C., Yang, Y.K., Chen, P.S., Lee, I.H., Yeh, T.L., Lu, R.B.Increased plasma leptin in antipsychotic-naïve females with schizophrenia, but not in males. Neuropsychobiology 2007;56 :213–215.CrossRefGoogle Scholar
White, R.T., Damm, D., Hancock, N., Rosen, B.S., Lowell, B.B., Usher, P., et al.Human adipsin is identical to complement factor D and is expressed at high level in adipose tissue. J Biol Chem 1992;267 :9210–9213.Google ScholarPubMed
Wu, R., Zhao, J., Shao, P., Ou, J., Chang, M.Genetic predictors of antipsychotic-induced weight gain: a case-matched multi-gene study. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011;36 :720–723.Google ScholarPubMed
Yevtushenko, O.O., Cooper, S.J., O'Neill, R., Doherty, J.K., Woodside, J.V., Reynolds, G.P.Influence of 5-HT2 C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia. Br J Psychiatry 2008;192 :424–428.CrossRefGoogle Scholar
Yu, Z., Han, S., Cao, X., Zhu, C., Wang, X., Guo, X.Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity 2012;20 :396–406.CrossRefGoogle ScholarPubMed
Zhang, H., Mo, X., Hao, Y., Gu, D.Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis. BMC Med Genet 2012;13 :40.CrossRefGoogle ScholarPubMed
Zhang, Z.J., Yao, Z.J., Mou, X.D., Chen, J.F., Zhu, R.X., Liu, W., et al.Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain (Abstract, Article in Chinese). Zhonghua Yi Xue Za Zhi 2003;83 :2119–2123.Google Scholar
Submit a response

Comments

No Comments have been published for this article.